3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
51
Fallopian Tube Neoplasms
28
Ovarian Neoplasms
23
Carcinoma, Non-Small-Cell Lung
22
Triple Negative Breast Neoplasms
15
Pancreatic Neoplasms
13
Breast Neoplasms, Male
11
Lung Neoplasms
10
Brenner Tumor
10
Inflammatory Breast Neoplasms
7
Uterine Cervical Neoplasms
5
Endometrial Adenocarcinoma
5
Adenocarcinoma of Lung
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Melanoma
4
Cholangiocarcinoma
4
Carcinoma, Ovarian Epithelial
4
Adenocarcinoma, Bronchiolo-Alveolar
4
Adenocarcinoma Of Esophagus
4
Pleural Effusion, Malignant
3
Pancreatic Adenocarcinoma
3
Neoplasms
3
Thymoma
2
Neurotoxicity Syndromes
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinosarcoma
2
Breast Carcinoma In Situ
2
Interventions
fludarabine phosphate
28
Peripheral Blood Stem Cell Transplantation
25
Cyclophosphamide
24
Whole-Body Irradiation
22
Busulfan
22
Tacrolimus
19
Mycophenolic Acid
19
Methotrexate
15
Antilymphocyte Serum
13
Cyclosporine
12
Melphalan
9
Filgrastim
9
Cytarabine
9
Etoposide
8
Cord Blood Stem Cell Transplantation
7
fludarabine
6
Thiotepa
6
Methylprednisolone
6
Imatinib Mesylate
5
Granulocyte Colony-Stimulating Factor
5
thymoglobulin
4
merphos
4
Sirolimus
4
Rituximab
4
Radiotherapy
4
Flow Cytometry
4
Dexamethasone
4
Dasatinib
4
Cyclosporins
4
Calcium Dobesilate
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Blast Crisis
×
Taxes
×
Clear all
No trials found.